Difference between revisions of "Cannabicyclohexanol"
From Wiki Weed
(Created page with "'''Cannabicyclohexanol (CCH, CP 47,497 dimethyloctyl homologue, (C8)-CP 47,497)''' is a cannabinoid receptor agonist drug, developed by Pfizer in 1979. On 19 January 2009, the...") |
(→See also) |
||
| Line 4: | Line 4: | ||
* [[Synthetic cannabis]] | * [[Synthetic cannabis]] | ||
* [[(C6)-CP 47,497]] | * [[(C6)-CP 47,497]] | ||
| − | * [[(C7)-CP 47,497]] (CP 47,497 itself) | + | * [[(C6)-CP 47,497|(C7)-CP 47,497]] (CP 47,497 itself) |
* [[(C9)-CP 47,497]] | * [[(C9)-CP 47,497]] | ||
* [[O-1871]] | * [[O-1871]] | ||
Latest revision as of 03:03, 14 April 2015
Cannabicyclohexanol (CCH, CP 47,497 dimethyloctyl homologue, (C8)-CP 47,497) is a cannabinoid receptor agonist drug, developed by Pfizer in 1979. On 19 January 2009, the University of Freiburg in Germany announced that an analog of CP 47,497 was the main active ingredient in the herbal incense product Spice, specifically the 1,1-dimethyloctyl homologue of CP 47,497, which is now known as cannabicyclohexanol. The 1,1-dimethyloctyl homologue of CP 47,497 is in fact several times more potent than the parent compound, which is somewhat unexpected as the 1,1-dimethylheptyl is the most potent substituent in classical cannabinoid compounds such as HU-210.
See also
- Synthetic cannabis
- (C6)-CP 47,497
- (C7)-CP 47,497 (CP 47,497 itself)
- (C9)-CP 47,497
- O-1871
